MedPath

A clinical trial to study the effects of the combination of modified Buerger-Allen exercise with Epsom-salt foot bath for the management of Chemotherapy-Induced peripheral neuropathy among breast cancer patients

Phase 1
Conditions
Health Condition 1: C50- Malignant neoplasm of breast
Registration Number
CTRI/2023/07/055716
Lead Sponsor
Rahul shil
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Symptomatic CIPN Breast cancer patients and asymptomatic CIPN breast cancer patients.

Exclusion Criteria

1.Patients who are terminally ill and having psychiatric conditions.

2.Patients who are suffering from diabetes, Diabetic neuropathy and other neurological symptoms.

3.Patients suffering from any other musculoskeletal disorders.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Buergers Allen exercise with Epsom salt foot bath may be used as an effective non pharmacological measures to treat chemotherapy induced peripheral neuropathy for breast cancer patients compared to BAE & Epsom salt foot bath alone <br/ ><br> <br/ ><br>Timepoint: 2nd / 3rd cycle chemotherapy for the baseline assessment and following assessment on 4th, 5th, and 6th cycle for symptomatic cases and 1st cycle chemotherapy for the baseline assessment and following assessment on 2nd, 3rd, 4th, 5th, and 6th assessment for asymptomatic cases
Secondary Outcome Measures
NameTimeMethod
The combination of modified Buerger-Allen exercise & Epsom-salt foot bath may also improve the overall quality of life of breast cancer patients during chemotherapyTimepoint: The quality of life will be checked in both symptomatic & asymptomatic breast cancer patients after each cycle of chemotherapy. 2nd / 3rd cycle chemotherapy for the baseline assessment & following assessment on 4th, 5th, & 6th cycle for symptomatic cases & 1st cycle chemotherapy for the baseline assessment & following assessment on 2nd, 3rd, 4th, 5th, & 6th assessment for asymptomatic cases.
© Copyright 2025. All Rights Reserved by MedPath